載入...
Safety of a Four‐factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials
OBJECTIVES: Clinicians often need to rapidly reverse vitamin K antagonists (VKAs) in the setting of major hemorrhage or urgent need for surgery. Little is known about the safety profile of the traditional reversal agent, plasma, or the newly approved agent, four‐factor prothrombin complex concentrat...
Na minha lista:
| 發表在: | Acad Emerg Med |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071715/ https://ncbi.nlm.nih.gov/pubmed/26822172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acem.12911 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|